Cutler Group’s Viking Therapeutics VKTX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2024
Q1 | $28K | Buy |
+350
| New | +$28K | 0.01% | 486 |
|
2023
Q4 | – | Sell |
-2,495
| Closed | -$27K | – | 2002 |
|
2023
Q3 | $27K | Sell |
2,495
-2,211
| -47% | -$23.9K | ﹤0.01% | 820 |
|
2023
Q2 | $76K | Buy |
4,706
+1,611
| +52% | +$26K | 0.01% | 528 |
|
2023
Q1 | $51K | Sell |
3,095
-2,005
| -39% | -$33K | 0.01% | 629 |
|
2022
Q4 | $47K | Sell |
5,100
-3,334
| -40% | -$30.7K | ﹤0.01% | 832 |
|
2022
Q3 | $22K | Hold |
8,434
| – | – | ﹤0.01% | 1171 |
|
2022
Q2 | $24K | Sell |
8,434
-900
| -10% | -$2.56K | ﹤0.01% | 1134 |
|
2022
Q1 | $28K | Buy |
+9,334
| New | +$28K | ﹤0.01% | 1249 |
|
2020
Q2 | – | Sell |
-19,300
| Closed | -$90K | – | 2152 |
|
2020
Q1 | $90K | Buy |
19,300
+14,300
| +286% | +$66.7K | ﹤0.01% | 621 |
|
2019
Q4 | $40K | Sell |
5,000
-3,000
| -38% | -$24K | ﹤0.01% | 969 |
|
2019
Q3 | $55K | Hold |
8,000
| – | – | 0.01% | 783 |
|
2019
Q2 | $66K | Hold |
8,000
| – | – | 0.01% | 820 |
|
2019
Q1 | $79K | Sell |
8,000
-4,200
| -34% | -$41.5K | 0.01% | 700 |
|
2018
Q4 | $93K | Sell |
12,200
-10,730
| -47% | -$81.8K | 0.01% | 638 |
|
2018
Q3 | $399K | Buy |
22,930
+9,060
| +65% | +$158K | 0.03% | 403 |
|
2018
Q2 | $131K | Buy |
+13,870
| New | +$131K | 0.01% | 615 |
|